Entries by Marc Mathys

More than half of today’s unicorn health startups haven’t published any influential research — and risk of another Theranos

April 4, 2020 in /by

Investors put hundreds of millions in Theranos despite its lack of published science. Few tech companies have crashed and burned in recent years like Theranos, a blood-testing startup that claimed it would revolutionize healthcare by doing away with “big bad needles.”  In the case of Theranos, launched over a decade ago by Stanford drop-out Elizabeth Holmes, investors put hundreds […]